SEC approves vaccine for kids, all you need to know

Aaj Tak 2021-10-12

Views 44

The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. The made in India vaccine will be administered in two doses, with a gap of 20 days between the first and second dose. Watch this episode of Khabardar to know everything about the vaccine for children.

Share This Video


Download

  
Report form